WALTER LORENZ TOTAL TEMPOROMANDIBULAR JOINT REPLACEMENT SYSTEM

FDA Premarket Approval P020016

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the total temporomandibular joint replacement system. The device is indicated for reconstruction of the temporomandibular joint. The reconstruction is necessary due to one of the following diagnoses: 1) arthritic conditions: osteoarthritis, traumatic arthritis, rheumatoid arthritis, 2) ankylosis including but not limited to recurrent ankylosis with excessive heterotopic bone formation, 3) revision procedures where other treatments have failed (e. G. Alloplastic reconstruction, autogenous grafts), 4) avascular necrosis, 5) multiply operated joints, 6) fracture, 7) functional deformity, 8) benign neoplasms, 9) malignancy (e. G. Post-tumor excision), 10) degenerated or resorbed joints with severe anatomic discrepancies, and 11) developmental abnormality.

DeviceWALTER LORENZ TOTAL TEMPOROMANDIBULAR JOINT REPLACEMENT SYSTEM
Generic NameJoint, Temporomandibular, Implant
ApplicantBIOMET MICROFIXATION, INC.
Date Received2002-05-13
Decision Date2005-09-21
Notice Date2005-10-05
PMAP020016
SupplementS
Product CodeLZD 
Docket Number05M-0399
Advisory CommitteeDental
Expedited ReviewNo
Combination Product No
Applicant Address BIOMET MICROFIXATION, INC. 1520 Tradeport Dr. jacksonville, FL 32218
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P020016Original Filing
S011 2019-11-18 30-day Notice
S010
S009
S008 2016-12-14 Normal 180 Day Track No User Fee
S007 2014-11-10 30-day Notice
S006 2012-01-27 30-day Notice
S005 2010-05-18 Normal 180 Day Track No User Fee
S004 2009-12-02 Real-time Process
S003 2009-09-24 Real-time Process
S002 2006-09-11 Normal 180 Day Track No User Fee
S001 2006-04-28 Normal 180 Day Track No User Fee

NIH GUDID Devices

Device IDPMASupp
00841036081898 P020016 006
00841036060428 P020016 006
00841036060398 P020016 006
00841036060343 P020016 006
00841036060329 P020016 006
00841036036621 P020016 006
00841036036607 P020016 006
00841036036584 P020016 006
00841036036560 P020016 006
00841036036546 P020016 006
00841036036522 P020016 006
00841036036508 P020016 006
00841036036454 P020016 006
00841036036430 P020016 006
00841036011895 P020016 006
00841036011871 P020016 006
00841036063580 P020016 006
00841036064884 P020016 006
00841036081881 P020016 006
00841036081874 P020016 006
00841036081867 P020016 006
00841036081805 P020016 006
00841036081799 P020016 006
00841036081782 P020016 006
00841036081744 P020016 006
00841036081737 P020016 006
00841036081720 P020016 006
00841036081713 P020016 006
00841036081560 P020016 006
00841036081553 P020016 006
00841036081386 P020016 006
00841036081348 P020016 006
00841036075118 P020016 006
00841036011857 P020016 006

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.